PGK1 and breast carcinoma: In addition, correlational studies involving patients with breast cancer revealed an association of PGK1 with paclitaxel resistance [175] and cell survival factors, such as HIF-1α [173] and immune checkpoints [176], although these need to be further investigated in future studies.